{"id":7958,"date":"2026-06-29T13:50:41","date_gmt":"2026-06-29T17:50:41","guid":{"rendered":"https:\/\/cqdm.org\/?p=7958"},"modified":"2026-06-29T13:54:29","modified_gmt":"2026-06-29T17:54:29","slug":"bio-2026-cqdm-and-investissement-quebec-bring-the-ecosystem-together-to-drive-biopharmaceutical-rd-collaborations","status":"publish","type":"post","link":"https:\/\/cqdm.org\/en\/news-and-events\/bio-2026-cqdm-and-investissement-quebec-bring-the-ecosystem-together-to-drive-biopharmaceutical-rd-collaborations\/","title":{"rendered":"BIO 2026: CQDM and Investissement Qu\u00e9bec bring the ecosystem together to drive biopharmaceutical R&D collaborations"},"content":{"rendered":"\n

On the sidelines of BIO 2026, CQDM and Investissement Qu\u00e9bec International brought together more than 100 life sciences stakeholders for a reverse pitch session aimed at accelerating biopharmaceutical R&D collaborations.<\/p>\n\n\n\n

A format designed to align industry needs with innovation<\/h2>\n\n\n\n

The reverse pitch format enables large pharmaceutical companies to present their priorities and R&D needs directly to the ecosystem. Researchers, entrepreneurs, and Canadian leaders engaged with international partners to explore concrete collaboration opportunities.<\/p>\n\n\n\n

Strong engagement across the ecosystem<\/h3>\n\n\n\n

The event brought together a diverse group of key players, fostering high-potential discussions. These direct exchanges help better align emerging innovations with real industry needs.<\/p>\n\n\n\n

Engagement from global pharmaceutical leaders<\/h3>\n\n\n\n

Several major pharmaceutical companies – including Amgen, Daiichi Sankyo, Johnson & Johnson, Ono Pharmaceutical, Otsuka, Pfizer, Sanofi, and Servier- actively participated in the session. We thank their representatives for the quality of the discussions and their openness.<\/p>\n\n\n\n

Advancing high-impact collaborations<\/h3>\n\n\n\n

These interactions provide a platform to identify tangible collaboration pathways and accelerate the development of innovative health solutions.<\/p>\n\n\n\n


At CQDM, this is precisely where we focus our efforts: connecting Canada\u2019s life sciences ecosystem with global pharmaceutical partners to foster impactful collaborations and drive innovation forward.<\/p>\n\n\n\n

A strong signal for Canada\u2019s global attractiveness<\/strong><\/h3>\n\n\n\n

This level of engagement sends a clear message: Qu\u00e9bec and Canada are emerging as partners of choice for biopharmaceutical R&D on the global stage.<\/p>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n<\/figure>\n","protected":false},"excerpt":{"rendered":"

On the sidelines of BIO 2026, CQDM and Investissement Qu\u00e9bec International brought together more than 100 life sciences stakeholders for a reverse pitch session aimed at accelerating biopharmaceutical R&D collaborations. A format designed to align industry needs with innovation The reverse pitch format enables large pharmaceutical companies to present their priorities and R&D needs directly…<\/p>\n","protected":false},"author":2,"featured_media":7955,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[15,1],"tags":[],"class_list":["post-7958","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events","category-our-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/7958","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/comments?post=7958"}],"version-history":[{"count":1,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/7958\/revisions"}],"predecessor-version":[{"id":7959,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/7958\/revisions\/7959"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/media\/7955"}],"wp:attachment":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/media?parent=7958"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/categories?post=7958"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/tags?post=7958"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}